Skip to main content
. 2020 Aug 5;10(8):1148. doi: 10.3390/biom10081148

Figure 1.

Figure 1

Predicted binding model of bevirimat (BVM) (A) and compounds 35 ((B−D), respectively) with HIV-1 capsid (CA) C-terminal domain (CTD)-spacer peptide 1 (SP1) protein.